Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP330472.RA8Sk1gRlTmaL4ac9jWWv0BdtzeLipeDcI6NYqCOFygac130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP330472.RA8Sk1gRlTmaL4ac9jWWv0BdtzeLipeDcI6NYqCOFygac130_assertion type Assertion NP330472.RA8Sk1gRlTmaL4ac9jWWv0BdtzeLipeDcI6NYqCOFygac130_head.
- NP330472.RA8Sk1gRlTmaL4ac9jWWv0BdtzeLipeDcI6NYqCOFygac130_assertion description "[We reported previously that treatment with all-trans retinoic acid (ATRA) and granulocyte macrophage colony-stimulating factor (GM-CSF) induces differentiation of human myeloblastic leukemia ML-1 cells to granulocytes, whereas treatment with ATRA alone induces practically no differentiation of these cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP330472.RA8Sk1gRlTmaL4ac9jWWv0BdtzeLipeDcI6NYqCOFygac130_provenance.
- NP330472.RA8Sk1gRlTmaL4ac9jWWv0BdtzeLipeDcI6NYqCOFygac130_assertion evidence source_evidence_literature NP330472.RA8Sk1gRlTmaL4ac9jWWv0BdtzeLipeDcI6NYqCOFygac130_provenance.
- NP330472.RA8Sk1gRlTmaL4ac9jWWv0BdtzeLipeDcI6NYqCOFygac130_assertion SIO_000772 10969805 NP330472.RA8Sk1gRlTmaL4ac9jWWv0BdtzeLipeDcI6NYqCOFygac130_provenance.
- NP330472.RA8Sk1gRlTmaL4ac9jWWv0BdtzeLipeDcI6NYqCOFygac130_assertion wasDerivedFrom befree-20150227 NP330472.RA8Sk1gRlTmaL4ac9jWWv0BdtzeLipeDcI6NYqCOFygac130_provenance.
- NP330472.RA8Sk1gRlTmaL4ac9jWWv0BdtzeLipeDcI6NYqCOFygac130_assertion wasGeneratedBy ECO_0000203 NP330472.RA8Sk1gRlTmaL4ac9jWWv0BdtzeLipeDcI6NYqCOFygac130_provenance.